Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma after orthotopic liver transplantation.

@article{Zhou2010ChemoembolizationWL,
  title={Chemoembolization with lobaplatin mixed with iodized oil for unresectable recurrent hepatocellular carcinoma after orthotopic liver transplantation.},
  author={Bin Zhou and Hong Shan and Kangshun Zhu and Zai-bo Jiang and Shou-hai Guan and Xiao-chun Meng and Xian-cheng Zeng},
  journal={Journal of vascular and interventional radiology : JVIR},
  year={2010},
  volume={21 3},
  pages={333-8}
}
PURPOSE To determine whether chemoembolization can benefit patients with unresectable recurrent hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT). MATERIALS AND METHODS Twenty-eight of 71 patients (39%) with unresectable recurrent HCC following OLT and without contradictions to chemoembolization were included: 14 patients received chemoembolization after OLT (chemoembolization group) and 14 matched control subjects who did not receive chemoembolization (non… CONTINUE READING